These Patients Struggle With Runaway Bones. Finally There’s Hope.

Early Paxlovid treatment was associated with modestly lower risks of Long COVID, post-acute hospitalization, and death among high-risk, nonhospitalized patients with COVID-19

Immunotherapy combo extends survival for patients with aggressive small cell lung cancer, based on trial results presented by Dana-Farber at ESMO Congress 2026

Endocrinologists who demonstrate greater medical knowledge more likely to prescribe a recommended treatment for patients with type 2 diabetes